|
|
|
 |
FDA Approval Activities for this Drug…
AmBisome (amphotericin B) Liposome Injection, Fujisawa Healthcare, NDA 50-740/S14 9/16/03 9/25/03 9/26/03 AmBisome (amphotericin B) Liposome Injection Fujisawa Healthcare, NDA 50-740/S-001 1/28/00 11/20/01 11/20/01 11/20/01 AmBisome (amphotericin B) Liposome Injection Fujisawa Healthcare, NDA 50-740/S-002 AMPHOTERICIN B Cream; Topical 3% FUNGIZONE APOTHECON 050724 AMPHOTERICIN B Injectable, Lipid Complex; Injection 5MG/ML ABELCET ENZON 050729 AMPHOTERICIN B Injectable, Lipid Complex; Injection 100MG/VIAL AMPHOTEC INTERMUNE 050729 AMPHOTERICIN B Injectable, Lipid Complex; Injection 50MG/VIAL AMPHOTEC INTERMUNE 050740 AMPHOTERICIN B Injectable, Liposomal; Injection 50MG/VIAL AMBISOME FUJISAWA 060517 AMPHOTERICIN B Injection 50MG/VIAL FUNGIZONE APOTHECON 064062 AMPHOTERICIN B Injection 50MG/VIAL AMPHOTERICIN B Gensia Sicor 063206 AMPHOTERICIN B Injection 50MG/VIAL AMPHOTERICIN B TEK 060570 AMPHOTERICIN B Lotion; Topical 3% FUNGIZONE APOTHECON | AmBisome (amphotericin B) Liposome Injection, Astellas Pharma US, Inc., Labeling Revision
  
|